Woman Talking To Man

Event in Chillicothe: Thursday 4/26, Dr. Ryan To Speak

Dr. Ryan, BrightView’s president and CMO, will be speaking at this event in Chillicothe tomorrow evening.  BrightView is excited to expand our services to Ross County by the end of 2018 and hope that we can be a part of the solution to this challenging epidemic.

Connection is the Opposite of Addiction. There are many local resources available to addicts and families wishing to connect; and people and organizations that are ready to help.

Join us for Addiction: Understanding Local Support and Resources, a free, community-focused forum on the health crisis of opioid addiction; and the help that is available in our region.

Hear from representatives from Adena Health System who will share how it is fast becoming a catalyst in saving lives, while fighting addiction. Also hear from experts about medication-assisted treatment; ambulatory detox options; and how the City of Chillicothe and Ross County are taking a proactive approach in reaching addicts and families following an overdose.

The event is free, but participants are asked to register. Light refreshments will be available.

To register, and get your free tickets, click the green REGISTER button below and follow the steps.

Register Button

Location: Adena PACCAR Medical, Education Center 446 Hospital Road, Chillicothe, OH 45601

When: Thursday April 26, 6:00pm-8:00pm EDT

View Map

Original post here.

PDF icon

Click the above PDF icon for the official addiction panel flier and feel free to share with anyone who might be interested in this event. If the above PDF does not work, please use the link below:

Addiction Panel Flier

signing a document

Gov. Kasich Proclaims April 23rd-29th, 2018 Addiction Treatment Week in Ohio

Today, April 24, 2018 in Columbus, Ohio, John Kasich, Governor of Ohio, signed a proclamation declaring April 23rd-29th, 2018 Addiction Treatment Week in Ohio. National Addiction Treatment Week, an initiative by the American Society of Addiction Medicine (ASAM), raises awareness that addiction is a disease, evidence-based treatments are available, and recovery is possible.

The adverse effects of the opioid epidemic and addiction in Ohio are evident. In 2016, Ohio had the second highest drug overdose death rate (39.1*) in the nation, according to the Centers for Disease Control and Prevention (CDC).[1]  The Ohio Department of Health reported that “unintentional drug overdoses caused the deaths of 4,050 Ohio residents [in 2016], a 32.8 percent increase compared to 2015 when there were 3,050 overdose deaths.[2]” The latest available data shows an average of 3,288 alcohol-related deaths per year in the state.[3]

The significant treatment gap for addiction in the United States (US) is an important part of the epidemic. Nearly 20.5 million Americans suffer from a substance use disorder (SUD), yet only 1 in 10 people with SUD receive treatment.[4] In 2015, nearly 2.3 million Americans suffered from opioid use disorder, yet there was only enough treatment capacity to treat 1.4 million people[5], leaving a treatment gap of nearly 1 million people.

Addiction Treatment Week

“We applaud Governor Kasich’s proclamation of Addiction Treatment Week and his continued efforts to combat an epidemic that is without precedent in Ohio.  Generating awareness that addiction is a disease, rather than a moral failure, is a crucial step to saving lives,” said Shawn Ryan, MD, FASAM, president of the Ohio Society of Addiction Medicine (OHSAM). “Given the high rate of drug overdose deaths in our state, we must all work together to increase patients’ access to evidence-based addiction treatments.  OHSAM is committed to helping physicians treat addiction and reduce the barriers to successful treatment and recovery.”

To learn more about National Addiction Treatment Week, how to get involved, and how to spread the word about the need for a larger addiction medicine workforce, visit www.TreatAddictionSaveLives.org.

Original announcement here.

* The number of deaths per 100,000 population [1] https://www.cdc.gov/nchs/pressroom/sosmap/drug_poisoning_mortality/drug_poisoning.htm [2] 2016 Ohio Drug Overdose Data: General Findings http://www.odh.ohio.gov/-/media/ODH/ASSETS/Files/health/injury-prevention/2016-Ohio-Drug-Overdose-Report-FINAL.pdf [3] https://www.cdc.gov/pcd/issues/2014/13_0293.htm[4] U.S. Department of Health and Human Services (HHS), Office of the Surgeon General, Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Washington, DC: HHS, November 2016. CH 4-2 [5]https://www.finance.senate.gov/imo/media/doc/101116%20Opioid%20Treatment%20Gap%20Report%20Final.pdf

 

Join Dr. Ryan Today 4/25 for a Webinar: Pathways to the Addiction Medicine Subspecialty

BrightView President and CMO, Dr. Shawn Ryan is one of the main speakers in this webinar: Pathways to the Addiction Medicine Subspecialty, today, April 25 @ 12:00 pm – 1:00 pm EDT.

This free webinar will begin with an overview of the current state of the addiction epidemic and the huge gap in addiction treatment. It will then move on to the role physicians can play to help close this gap, and the importance to sit for the ABPM Addiction Medicine exam. The webinar will then move on to a representative from ABPM discussing the details of how physicians can apply for the ADM exam and any “lessons learned” from last year. This webinar is ideal for any physician interested in addiction medicine, ABAM Diplomates, DATA 2000 waivered physicians, medical directors, and others.

Speakers/Presenters:

  • Shawn Ryan, MD, MBA  President of OHSAM (Ohio state chapter of ASAM)
  • Michael Weaver, MD, FASAM  Professor at The University of Texas Health Science Center at Houston (UTHealth)
  • Steve Daviss, MD  Senior Medical Advisor, Office of the CMO at SAMHSA

Click on the blue “register” icon below to register or visit this link. 

Register Button Addiction Treatment week statistic

Tallying Score

Ohio Addiction Policy Inventory and Scorecard

This report is the first in a series of inventories and scorecards analyzing Ohio’s policy response to the addiction crisis and outlining areas where the state could be more effective.

The report provides policymakers and other stakeholders with the information needed to take stock of Ohio’s policy response to the addiction crisis over the past five years by reviewing state-level policy changes enacted in Ohio from 2013-2017. It includes:

  • An inventory of policy changes (legislation, rules, regulations and new or expanded state agency initiatives, programs, systems changes or guidelines) 
  • A scorecard that indicates the extent to which Ohio is implementing strategies that are proven effective by research evidence
  • Opportunities for improvement in both the public and private sectors

The report focuses on the first three elements of a comprehensive policy response to addiction: prevention, treatment and recovery. HPIO plans to develop similar inventories and scorecards for other key elements in 2018 and 2019 (see graphic below).

Key Findings For Policy Makers

In 2016, 4,050 Ohioans died because of  unintentional drug overdoses, and preliminary 2017 data indicates that the number of deaths has continued to rise.

The consequences of addiction are widespread. For example, the number of babies born with neonatal abstinence syndrome (NAS) increased 500 percent in the past 10 years and thousands of children experience trauma because they live in families struggling with addiction. Employers report difficulty hiring drug-free workers, and researchers estimate that the opioid crisis cost Ohio $3,385 per capita in healthcare and criminal justice spending and reduced worker productivity in 2015. 

Public and private stakeholders have worked hard to understand and address the crisis. Policy changes advanced by the executive and legislative branches have led to implementation of many evidence-based programs in Ohio, reduced the amount of opioid prescriptions dispensed and increased health insurance coverage and treatment access for thousands of Ohioans through expanded Medicaid eligibility.

Addiction Scorecard

Although this report has a strong focus on prescription opioids and other opiates, the detailed inventory and scorecard (available below) also review policy changes related to several other substances (alcohol, tobacco, methamphetamine, cocaine, etc.).HPIO logo

The report is part HPIO’s Addiction Evidence Project, which provides policymakers and other stakeholders with information needed to address substance use disorders in a comprehensive, effective and efficient way. This inventory and scorecard addresses three topics: prevention, treatment and recovery. Future reports will address the other topics listed below, including overdose reversal (naloxone).

Additional resources on addiction prevention, treatment and recovery

Link to original site here.

Group of Five in Circle

Today is the 1st day of Addiction Treatment Week! Free Webinar @ Noon Today!

Today is the 1st day of Addiction Treatment Week! Follow BrightView for continuous coverage on all events, major announcements and everything related to this!

Also, be sure to tune in today for a free webinar from 12pm-1:00pm titled:

Improving the Language & Coverage of Addiction

Brought to you by:

ASAM.org and http://treataddictionsavelives.org

Register for free webinar here.

About the webinar: reflecting new scientific understanding of addiction, this webinar will offer guidance on how the media can accurately and fairly cover addiction through language, point-of-view, and style. The medical understanding of addiction and the science behind the disease has changed significantly. While the medical community changes the way it treats addiction, the media is also changing the way it covers addiction. The webinar will consider the stigma surrounding addiction and how the way the media covers the disease affects the public perception of the disease. Importantly, the webinar also will discuss the recent changes made to the AP Stylebook about the word “addict” and other stigmatizing words.

Speakers:

  • Michael Botticelli, Former Director of the White House Office of National Drug Control Policy
  • Sarah E. Wakeman, MD, FASAM, Medical Director of the Massachusetts General Hospital Substance Use Disorder Initiative
  • Jeff McMillan, Eastern US Enterprise Editor for The Associated Press and AP Stylebook Committee Member

Addiction Treatment Week

Teacher listening to students at an adult education class

To fight opioid addiction, call it what it is: an emergency and a preventable disease

We must recognize that opioid addiction is a life-threatening emergency, a chronic disease, and a preventable condition. It takes a community to fight it.

Another opioid overdose death. Another drug-related crime. Another billion dollars spent on ineffective treatments. News about the opioid crisis keeps getting worse. Simple solutions haven’t changed the epidemic’s course.

The number of deaths has continued to increase, driven by an influx of illicit fentanyl that is laced into counterfeit pain pills, heroin and other illegal drugs. To effectively treat this evolving public health crisis, we must recognize opioid addiction for what it is.

Opioid addiction is an emergency. Just as providing first aid for cardiac arrest requires a defibrillator and first aid for severe bleeding requires a tourniquet, first aid for an opioid overdose requires naloxone. Last year, Alaska Governor Bill Walker declared the state’s opioid epidemic a public health emergency and made naloxone more readily available to all Alaskans. The U.S. Surgeon General’s recent Health Advisory calls for increasing the drug’s public availability: Too often, it is not available when needed. And just as other emergencies follow first aid with immediate medical care, the same strategy should be used for opioid addiction.

Opioid addiction is a chronic disease that requires ongoing care. Addiction rewires parts of the brain that process reward and motivation, resulting in inexplicably self-destructive behavior. Like other chronic diseases, opioid addiction can be managed: People who’ve experienced addiction can return to successful and productive lives. Yet, only one in 10 people with opioid addiction is receiving treatment. Why? A lack of treatment providers is one barrier. An equal challenge is stigma — for too long, addiction has been considered a moral failing or a habitual series of “bad choices.” Drug experimentation is a bad choice, but no one chooses a life hijacked by opioid addiction any more than a smoker chooses lung cancer.

Opioid addiction is treatable with medication. Combined with psychological and social support, Medicated Assisted Treatment (MAT) is the most effective path to recovery. Yet too many people dismiss MAT as exchanging one addiction for another. Just as people with Type II diabetes or asthma do best with a combination of medication and lifestyle changes, a multi-pronged approach that includes medication is the best way to treat opioid addiction. Like other chronic diseases, addiction requires long-term management. Also, many do not know that the risk of overdose increases after a period of abstinence; thus, a few weeks in detox is not enough without further treatment and can lead to relapse or death.

Opioid addiction is preventable. Prevention requires addressing supply and demand. On the supply side, sound pain-management strategies will result in better pain control, fewer people becoming addicted to prescription opioids, and fewer painkillers sitting in our medicine cabinets for others to misuse. Interdiction by law enforcement can also reduce the amount of illicit drugs entering the market.

However, addressing the supply side alone will not solve this crisis. We have to address the demand for opioids. This means confronting the thorny issues that make opioids an attractive escape for many, including unemployment, homelessness, poverty, boredom and racism. It will require learning how to prevent and mitigate the lifelong effects of adverse childhood experiences, and building resilient people and communities.

How can we possibly do all this? An Iñupiaq whaler recently offered me his insight on the opioid crisis by asking, “How do you eat a whale?” As I considered this very Alaskan version of an old saw about elephants, he explained: One person does not go into the sea to take a whale. One person does not butcher a 100-ton whale. And, no, you do not eat a whale one bite at a time.

You take and eat a whale as a community.

Isolation is the fertile ground in which addiction blossoms and our responses fail. It is time for us to come together as communities, tribes and states to call opioid addiction what it is, and respond accordingly.

Dr. Jay C. Butler is chief medical officer at the Alaska Department of Health and Social Services and immediate past-president of the Association of State and Territorial Health Officials.

Original article here on USAToday.com.

USA Today logo

The White House

Opioid Crisis Takes Personal Toll on Washington

The opioid crisis is hitting families across the nation regardless of income, race or gender. Lawmakers are no exception. In the past few months, The Hill has talked to a number of House and Senate members who have a personal connection to addiction and the opioid epidemic. This is the first in a five-part series presented by Partnership for Safe Medicine.

The epidemic has put enormous strain on health care responders, treatment providers and communities across the country, creating a health emergency that shows no signs of abating.

Yet despite the gravity of the problem, there’s a sense from some that the nation isn’t doing enough to stem the crisis.

Congress has approved $6 billion in new spending over the next two years to combat opioid abuse and bolster mental health services, but some say that is a drop in the bucket compared to what’s needed.

“If it were some other illness, we would be throwing exponentially more dollars at this than we are,” said Patrick Kennedy, a former Rhode Island Democratic congressman who’s now a vocal advocate for fighting drug addiction.

Text Grab Opioids

“We would be mobilizing significantly more federal resources toward tackling this. We would be marshaling every agency within the federal government to attack this,” said Kennedy, who served on the president’s commission to combat the opioid epidemic last year and has since been critical of the White House’s response to the crisis.

Deaths involving opioids have been rising since 1999. They increased nearly 28 percent from 2015 to 2016, an increase largely driven by a synthetic opioid packing up to 50 times more power than heroin.

An estimated 115 people are dying of an opioid-related overdose every day. When members of Congress return to their districts, they say they hear first-hand how painkillers, heroin and fentanyl are wrecking lives — and that’s resulted in a sea change in attitudes about drug abuse.

The notion that addiction is a disease, rather than a moral failing, is increasingly the consensus.

“My old boss, Michael Botticelli [former President Obama’s drug czar], would say all the time, ‘you can’t hate up close,’ ” said Regina LaBelle, the White House Office of National Drug Control Policy’s chief of staff under Obama.

Opioid Overdose Deaths GraphOpioid Overdose Deaths Graph 2

The shift in perspective has resulted in a less punitive response than in the past. In the 1980s, for example, policymakers responded to the crack cocaine epidemic by launching the “war on drugs” and creating mandatory minimum prison sentences for drug offenders.

“If your brother or your sister or your neighbor is dying of a drug overdose, you are less likely to want to have a punitive response, and the difference in what happened today than what happened in the ’80s reflects that,” LaBelle said.

Advocates working on addiction policy say it has also gotten easier to publicize the problem.

More than 15 years ago, when Andrew Kessler first began working in the field, he said advocates “had to fight for every bit of attention we got.”

Kessler, the founder of the behavioral health consulting firm Slingshot Solutions, recalled a presentation he gave in 2013 on addiction advocacy.

“The reason we can’t get a lot of traction is because no member of Congress is going to go home to their districts and say, ‘I’m running on a platform of treating substance abuse and addiction,’ ” Kessler recalled telling the crowd.

“Three years later, in the 2016 election — boom — I was already wrong,” Kessler said.

Kessler attributes the turnaround to the increasing number of opioid overdose deaths, which rose nearly 70 percent between 2013 and 2016.

Drug OVerdose Deaths Map

The response from policymakers is improving, though much more is needed, said Patty McCarthy Metcalf, the executive director of Faces and Voices of Recovery.

“Getting Congress to take this issue up took a lot of work and a lot of advocacy from the grass roots to put pressure on Congress to understand that this didn’t happen overnight, it’s been coming for a while,” she said. “The rate [of opioid-related overdose deaths] has been increasing — we haven’t seen it decreasing, so something is not working.”

Efforts are underway in both chambers to produce opioid legislation, which could be one of the only larger legislative packages to pass before the midterm elections in November.

The House Energy and Commerce Committee has held three legislative hearings on more than 65 separate bills with the goal of getting an opioid package to the House floor before Memorial Day weekend.

On the other side of the Capitol, a bipartisan group of eight senators introduced a follow up to the Comprehensive Addiction and Recovery Act, passed in 2016, dubbing the bill “CARA 2.0.” One of the bill’s most controversial provisions is a three-day limit on first-time opioid prescriptions for patients with acute pain.

Earlier this month, the leaders of the Senate Health Committee released a bipartisan discussion draft of an opioid bill, which the panel reviewed at a hearing last week and will mark up April 24.

The Trump administration is also pushing for action.

Declaring “we can be the generation that ends the opioid epidemic,” President Trump made opioids a national public health emergency in late October. But some advocates have expressed frustration with that move, saying it has led to little concrete action.

Last month, Trump released a three-pronged approach to tackle the opioid epidemic, which included some measures popular with public health advocates.

But a portion of Trump’s rhetoric, and a bulk of the subsequent media attention, focused on the inclusion of a controversial provision — mandating that the Department of Justice seek the death penalty for some drug traffickers, when appropriate under current law.

Advocates have said the concept is reminiscent of the war-on-drugs approach that failed in the past.

Instead, they say a focus on prevention, treatment and recovery is what’s needed, as advocates work to stomp out the stigma of addiction. Some progress is being made on that front, advocates say, with more people coming forward to say they have an addiction or lost a loved one to a drug overdose.

“You can see it in the obituaries,” Kennedy said, “literally for the first time ever, you’re seeing on a regular basis people actually acknowledge the true cause of death for people dying of overdoses.”

Kaitlin Milliken contributed to this report. Graphics and illustration by Nicole Vas. Video by Tom Pray.

Original article here on thehill.com.

silhouette of a jogger in sunrise

Naltrexone: What Should Patients Expect With First Dose?

This two-part video gives both providers and patients detailed information about naltrexone, including benefits and possible side effects following the injection.

Dr. Mariani, Associate Professor of Clinical Psychiatry at the College of Physicians and Surgeons of Columbia University, is a PCSS clinical expert.  He discusses naltrexone with a patient who has chosen that medication to treat her opioid use disorder.

Part 1

Part 2

View more videos at pccsNOW.org

PCCS Video Series logo

Business People Joining Hands in Unity

Enquirer Wins Pulitzer Prize for Seven Days of Heroin Coverage

The Cincinnati Enquirer staff has won a Pulitzer Prize in the local reporting category, and BrightView’s Amy Parker is featured in this winning documentary.  The story “Seven Days of Heroin” was recognized by the Pulitzer board “for a riveting and insightful narrative and video documenting seven days of greater Cincinnati’s heroin epidemic, revealing how the deadly addiction has ravaged families and communities.”

The Enquirer sent more than 60 reporters, videographers and photographers into the community to chronicle the story.

“I’m so thrilled and happy for the staff of The Enquirer,” said Peter Bhatia, editor and vice president of the Detroit Free Press who led The Enquirer when the story was published. “This project was the product of the entire staff and everyone, everyone there deserves credit for it.

“It was not only our great journalists being rewarded, but a fantastic newsroom family is being rewarded.”

The story chronicled an “ordinary” week for people dealing with the heroin crisis, from those facing addiction and their families, to paramedics and police officers.

Cinci Enquirer Logo

“My hope is that the Pulitzer recognition, so richly deserved, exposes even more people to the project, because the events chronicled in Seven Days of Heroin continue, and people remain desperate for help,” said Enquirer Editor Beryl Love.

Two other newsrooms in Gannett, The Enquirer’s parent company, also won Pulitzer Prizes. The staffs of The Arizona Republic and USA Today Network won for “The Wall,” an examination of every mile of U.S.-Mexico border. Andie Dominick of The Des Moines Register won for editorial writing.

This is the second Pulitzer win for The Enquirer. Jim Borgman won for editorial cartooning in 1991.

Read and watch the award-winning project:

https://www.cincinnati.com/story/news/2018/04/16/enquirer-wins-pulitzer-prize-seven-days-heroin-coverage/521772002/

 

Image of Business Document

ASAM and the AMA Announce Innovative Payment Model to Improve Treatment of Opioid Use Disorder

Washington, D.C. – The American Society of Addiction Medicine (ASAM) and the American Medical Association (AMA) jointly announced today the release of a concept paper detailing a groundbreaking alternative payment model (APM) that could revolutionize how patients with opioid use disorder are treated.

The new payment model, known as Patient-Centered Opioid Addiction Treatment (P-COAT), is expected to increase the number of patients with opioid use disorder who are able to lead satisfying, productive lives through successful management of their condition while also reducing health care spending on costs associated with addiction, such as emergency department visits and hospitalizations.

“We have seen significant increases in the rate of individuals dying from opioid poisonings across the United States once again this year,” said Kelly J. Clark, MD, MBA, DFAPA, DFASAM, president of ASAM. “At the same time, millions of individuals across the country continue to lack access to treatment due to insurance reimbursement and coverage barriers. I am proud of the AMA-ASAM APM Working Group for developing a framework that seeks to address these issues.”

The new payment model seeks to increase utilization of and access to medications for the treatment of opioid use disorder by providing the appropriate financial support to successfully treat patients and broaden the coordinated delivery of medical, psychological, and social support services. P-COAT is also designed to support office-based opioid treatment in order to facilitate coordination between multiple treatment providers. Previously, payment for these services has been segregated, which contributes to patient difficulties receiving comprehensive care.

“Arbitrary limitations on effective, comprehensive treatment are stymying physician efforts to treat patients with opioid use disorder,” said Patrice A. Harris, MD, MA, chair of the AMA Opioid Task Force. “This new tool will remove a brick in the wall that prevents patients from accessing needed treatment. Eventually, this wall will be torn down. Until then, we must continue fighting for our patients and remove arbitrary barriers to care.”

The P-COAT APM is based on a wealth of research showing that medications combined with psychosocial supports is effective in treating individuals with opioid use disorder. Unfortunately, the current physician payment system offers little support for the coordination of behavioral, social and other support services that patients being treated for opioid use disorder need in addition to their medication. Non-face-to-face services – such as phone calls and email consultations with patients – in addition to better coordination between specialists, outpatient treatment programs and other health providers such as emergency rooms, are essential to the delivery of effective, evidence-based treatment to the individuals who need it.

“The current physician reimbursement structure does not account for all the services that patients with an opioid use disorder need to progress to successful treatment and recovery,” said Shawn Ryan, MD, MBA, ABEM, ABAM, FASAM, chair of the AMA-ASAM APM Working Group and ASAM’s Payer Relations Committee. “While we know that a combination of medication and psychosocial support systems is the evidence-based standard for treatment, we continue to find that patients are not able to access treatment due to limited or non-existent insurance coverage. We hope that today’s announcement will begin a national conversation with insurers and policymakers about what it takes for successful treatment and recovery.”

AMA logo

ASAM logo

For more information about the P-COAT APM, please review ASAM’s issue brief here.
The complete P-COAT APM is available here..

Media Contacts:
Rebecca Reid (ASAM)
(410) 212-3843
rreid@schmidtpa.com

Jack Deutsch (AMA)
(202) 789-7442
jack.deutsch@ama-assn.org